Crucell and its partner DSM Biologics have appointed Dr. Marco Cacciuttolo chief executive officer of the two companies joint PER.C6 R&D Center, which will be located in Cambridge, MA. Dr. Cacciuttolo joins the venture with more than 10 years of experience in technical operations within the pharma and biopharma industries. Dr. Cacciuttolo has held positions of increasing responsibility at MedImmune, Inc. and most recently at Medarex, Inc. as the vice president of technical operations. ...